Artificial Pancreas - Medical Devices Pipeline Assessment, 2019

Artificial Pancreas - Medical Devices Pipeline Assessment, 2019

Artificial Pancreas - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Artificial Pancreas - Medical Devices Pipeline Assessment, 2019 provides an overview of Artificial Pancreas currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Artificial Pancreas pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Artificial Pancreas under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Artificial Pancreas under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


  • Introduction
    • Artificial Pancreas Overview
  • Products under Development
    • Artificial Pancreas - Pipeline Products by Stage of Development
      • Table Figure 1: Artificial Pancreas - Pipeline Products by Stage of Development
      • Table Artificial Pancreas - Pipeline Products by Stage of Development
    • Artificial Pancreas - Pipeline Products by Territory
      • Table Figure 2: Artificial Pancreas - Pipeline Products by Territory
      • Table Artificial Pancreas - Pipeline Products by Territory
    • Artificial Pancreas - Pipeline Products by Regulatory Path
      • Table Figure 3: Artificial Pancreas - Pipeline Products by Regulatory Path
      • Table Artificial Pancreas - Pipeline Products by Regulatory Path
    • Artificial Pancreas - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Artificial Pancreas - Pipeline Products by Estimated Approval Date
      • Table Artificial Pancreas - Pipeline Products by Estimated Approval Date
    • Artificial Pancreas - Ongoing Clinical Trials
      • Table Figure 5: Artificial Pancreas - Ongoing Clinical Trials
      • Table Artificial Pancreas - Ongoing Clinical Trials
  • Artificial Pancreas - Pipeline Products under Development by Companies
    • Artificial Pancreas Companies - Pipeline Products by Stage of Development
      • Table Artificial Pancreas Companies - Pipeline Products by Stage of Development
    • Artificial Pancreas - Pipeline Products by Stage of Under Development
      • Table Artificial Pancreas - Pipeline Products by Stage of Under Development
  • Artificial Pancreas Companies and Product Overview
    • Admetsys Corp Company Overview
      • Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Admetsys Smart Pancreas - Product Status
        • Table Admetsys Smart Pancreas - Product Description
    • Advanced Biosensors-Ohio LLC (Inactive) Company Overview
      • Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Biosensors-Ohio LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artificial Pancreas - Product Status
        • Table Artificial Pancreas - Product Description
    • Beta Bionics Inc Company Overview
      • Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table iLet - Bi-harmonal Closed loop System - Product Status
        • Table iLet - Bi-harmonal Closed loop System - Product Description
        • Table iLet Bionic Pancreas - Glucagon Version - Product Status
        • Table iLet Bionic Pancreas - Glucagon Version - Product Description
        • Table iLet Bionic Pancreas - Insulin-only Version - Product Status
        • Table iLet Bionic Pancreas - Insulin-only Version - Product Description
        • Table Beta Bionics Inc - Ongoing Clinical Trials Overview
        • Table iLet - Bi-harmonal Closed loop System - Bihormonal Bionic Pancreas for the Treatment of Diabetes Post-Pancreatectomy in Children With Congenital Hyperinsulinism - A Pilot Study
        • Table iLet - Bi-harmonal Closed loop System - Feasibility of Outpatient Automated Blood Glucose Control with the Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
        • Table iLet Bionic Pancreas - Insulin-only Version - Individualizing Automated Closed Loop Glucose Control through Pharmacokinetic Profiling in an Insulin-only Bionic Pancreas
        • Table iLet Bionic Pancreas - Insulin-only Version - The Set-point Study for Type 2 Diabetes: Evaluating the Safety and Efficacy of an Insulin only Bionic Pancreas System in Patients with Type 2 Diabetes
    • Beta-O2 Technologies Ltd Company Overview
      • Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ßAir Bio-artificial Pancreas - Product Status
        • Table ßAir Bio-artificial Pancreas - Product Description
        • Table Beta-O2 Technologies Ltd - Ongoing Clinical Trials Overview
        • Table ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-air in Patients with Type 1 Diabetes Mellitus
    • Bigfoot Biomedical Inc Company Overview
      • Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bigfoot smartloop System - Product Status
        • Table Bigfoot smartloop System - Product Description
    • BioTex Inc Company Overview
      • BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioTex Inc Artificial Pancreas - Product Status
        • Table BioTex Inc Artificial Pancreas - Product Description
    • Cerco Medical LLC Company Overview
      • Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Islet Sheet - Product Status
        • Table Islet Sheet - Product Description
    • Converge Biotech, Inc. Company Overview
      • Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioartificial Pancreas System - Product Status
        • Table Bioartificial Pancreas System - Product Description
    • Covalor Medical, LLC Company Overview
      • Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalor Medical, LLC Artificial Pancreas - Product Status
        • Table Covalor Medical, LLC Artificial Pancreas - Product Description
    • De Montfort University Company Overview
      • De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
        • Table De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
        • Table InSmart Artificial Pancreas - Product Status
        • Table InSmart Artificial Pancreas - Product Description
    • Debiotech SA Company Overview
      • Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Artificial Pancreas - Product Status
        • Table Next Generation Artificial Pancreas - Product Description
    • Defymed SAS Company Overview
      • Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table MAILPAN - Product Status
        • Table MAILPAN - Product Description
    • Diabeloop Company Overview
      • Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diabeloop Pipeline Products & Ongoing Clinical Trials Overview
        • Table DBLG1 - Adults - Product Status
        • Table DBLG1 - Adults - Product Description
        • Table DBLG1 - Pediatric Version - Product Status
        • Table DBLG1 - Pediatric Version - Product Description
        • Table Diabeloop - Ongoing Clinical Trials Overview
        • Table DBLG1 - Adults - An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared with Sensoraugmented Pump Therapy, in Young Children with Type 1 Diabetes
    • EOFlow Co Ltd Company Overview
      • EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table EOPancreas - Product Status
        • Table EOPancreas - Product Description
    • Giner Inc Company Overview
      • Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BAPIOS System - Product Status
        • Table BAPIOS System - Product Description
    • Harvard John A Paulson School of Engineering and Applied Sciences Company Overview
      • Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pregnancy-Specific Artificial Pancreas - Product Status
        • Table Pregnancy-Specific Artificial Pancreas - Product Description
        • Table Harvard John A Paulson School of Engineering and Applied Sciences - Ongoing Clinical Trials Overview
        • Table Pregnancy-Specific Artificial Pancreas - Observational Study of Patient Important Outcomes in Pregnant Patients with Type 1 Diabetes Mellitus on Insulin Pump
    • Healios Inc Company Overview
      • Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioengineered Pancreas - Product Status
        • Table Bioengineered Pancreas - Product Description
    • Imperial College London Company Overview
      • Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio-inspired Artificial Pancreas - Product Status
        • Table Bio-inspired Artificial Pancreas - Product Description
    • Inreda Diabetic BV Company Overview
      • Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bi-Hormonal Artificial Pancreas - Product Status
        • Table Bi-Hormonal Artificial Pancreas - Product Description
        • Table Bi-Hormonal Artificial Pancreas - Lighter Version - Product Status
        • Table Bi-Hormonal Artificial Pancreas - Lighter Version - Product Description
        • Table Inreda Diabetic BV - Ongoing Clinical Trials Overview
        • Table Bi-Hormonal Artificial Pancreas - Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, APPEL 5
    • Insulet Corp Company Overview
      • Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Omnipod Horizon Hybrid Closed Loop System - Product Status
        • Table Omnipod Horizon Hybrid Closed Loop System - Product Description
    • Kencak LLC Company Overview
      • Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioArtificial Pancreas - Product Status
        • Table BioArtificial Pancreas - Product Description
    • Medicsensors SL Company Overview
      • Medicsensors SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medicsensors SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medicsensors SL Artificial Pancreas - Product Status
        • Table Medicsensors SL Artificial Pancreas - Product Description
    • Medtronic Diabetes Company Overview
      • Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
        • Table MiniMed 640G System - Product Status
        • Table MiniMed 640G System - Product Description
        • Table Minimed 780G - Product Status
        • Table Minimed 780G - Product Description
        • Table Minimed 890G - Product Status
        • Table Minimed 890G - Product Description
        • Table Third-Generation Artificial Pancreas System - Product Status
        • Table Third-Generation Artificial Pancreas System - Product Description
        • Table Medtronic Diabetes - Ongoing Clinical Trials Overview
        • Table MiniMed 640G System - A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch for Clinical Islet Transplantation
        • Table MiniMed 640G System - An Open-label, Multicenter, Randomized, Single-period, Parallel Design Study to Assess the Effect of Closed Loop Insulin Delivery from Onset of Type 1 Diabetes in Youth on Residual Beta Cell Function Compared to Standard Insulin Therapy
        • Table MiniMed 640G System - Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump Coupled with the Continuous Measurement of Interstitial Glycemia in Type 1 Diabetic Adults
        • Table Minimed 780G - Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children with Type 1 Diabetes Treated with Insulin Pump
        • Table Minimed 780G - Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
    • Miromatrix Medical Inc Company Overview
      • Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Miro Pancreas - Product Status
        • Table Miro Pancreas - Product Description
    • Pacific Diabetes Technologies, Inc. Company Overview
      • Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artificial Endocrine Pancreas - Product Status
        • Table Artificial Endocrine Pancreas - Product Description
    • Pancreum, LLC Company Overview
      • Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Genesis Artificial Pancreas - Product Status
        • Table Genesis Artificial Pancreas - Product Description
    • PharmaCyte Biotech Inc Company Overview
      • PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bio-Artificial Pancreas - Product Status
        • Table Bio-Artificial Pancreas - Product Description
    • Polytechnic University of Valencia Company Overview
      • Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
        • Table Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClosedLoop 4Meal - Product Status
        • Table ClosedLoop 4Meal - Product Description
    • Rensselaer Polytechnic Institute Company Overview
      • Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
        • Table Closed-Loop Artificial Pancreas System - Product Status
        • Table Closed-Loop Artificial Pancreas System - Product Description
    • Senseonics Holdings Inc Company Overview
      • Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Status
        • Table Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Description
        • Table Senseonics Holdings Inc - Ongoing Clinical Trials Overview
        • Table Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
    • Tandem Diabetes Care Inc Company Overview
      • Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table t:slim X2 Pump With Dexcom G6 and HCL - Product Status
        • Table t:slim X2 Pump With Dexcom G6 and HCL - Product Description
        • Table Tandem Diabetes Care Inc - Ongoing Clinical Trials Overview
        • Table t:slim X2 Pump With Dexcom G6 and HCL - An Extension Study of t:Slim X2 with Control-IQ Technology
        • Table t:slim X2 Pump With Dexcom G6 and HCL - Assessment of the Efficacy of Closed-loop Insulin Therapy (Artificial Pancreas) on the Control of Type 1 Diabetes in Prepubertal Child in Free-life: Comparison Between Nocturnal and 24-hour Use on 18 Weeks, Followed by an Extension on 18 Weeks
    • TecMed Inc Company Overview
      • TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TecMed Artificial Pancreas - Product Status
        • Table TecMed Artificial Pancreas - Product Description
    • The Alfred Mann Foundation Company Overview
      • The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Artificial Pancreas Device - Product Status
        • Table Implantable Artificial Pancreas Device - Product Description
    • TypeZero Technologies LLC Company Overview
      • TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table inControl - Product Status
        • Table inControl - Product Description
        • Table TypeZero Technologies LLC - Ongoing Clinical Trials Overview
        • Table inControl - Clinical Acceptance of the Artificial Pancreas: The International Diabetes Closed Loop (iDCL) Trial: A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
        • Table inControl - Examination of New Control Algorithm of inControl AP
        • Table inControl - Pilot Evaluation Study of the Feasibility of a Permanent Use in Free-life of inControl Artificial Pancreas System for the Treatment of Type 1 Diabetes
    • Universidad Autonoma de Madrid Company Overview
      • Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
        • Table Predictive Rule-Based Algorithm - Product Status
        • Table Predictive Rule-Based Algorithm - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Implantable Bioartificial Pancreas - Product Status
        • Table Implantable Bioartificial Pancreas - Product Description
    • University of California Santa Barbara Company Overview
      • University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
        • Table Closed-Loop Artificial Pancreas - Product Status
        • Table Closed-Loop Artificial Pancreas - Product Description
        • Table Pediatric Artificial Pancreas - Product Status
        • Table Pediatric Artificial Pancreas - Product Description
    • University of Cambridge Company Overview
      • University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
        • Table Florence D2A System - Product Status
        • Table Florence D2A System - Product Description
        • Table FlorenceM - Product Status
        • Table FlorenceM - Product Description
    • University of Florida Company Overview
      • University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioartificial Pancreas - Type 1 Diabetes - Product Status
        • Table Bioartificial Pancreas - Type 1 Diabetes - Product Description
    • University of Newcastle Company Overview
      • University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
        • Table Closed Glucose-Sensing Insulin-Delivery System - Product Status
        • Table Closed Glucose-Sensing Insulin-Delivery System - Product Description
    • XERIS Pharmaceuticals Inc Company Overview
      • XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table XERIS Pharmaceuticals Inc Bi-Hormonal Artificial Pancreas - Product Status
        • Table XERIS Pharmaceuticals Inc Bi-Hormonal Artificial Pancreas - Product Description
    • Yale University Company Overview
      • Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Yale University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Automated Insulin Delivery System - Product Status
        • Table Automated Insulin Delivery System - Product Description
  • Artificial Pancreas - Recent Developments
    • Jun 09, 2019: Tandem Diabetes Care reports positive results from two studies of the t:slim X2 Insulin Pump With Control-IQ Technology
    • Jun 09, 2019: Insulet's Omnipod Horizon Hybrid Closed-Loop System improves Glycemic Control in patients as young as two years Old with Type 1 Diabetes
    • Jun 08, 2019: Medtronic initiates pivotal trial for Bluetooth enabled MiniMed 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing
    • Jun 08, 2019: The iLet Bionic Pancreas Increased Time in Range for Adults with Type 1 Diabetes
    • Jun 07, 2019: Beta Bionics reports positive data from iLet Bionic Pancreas' study
    • Jun 07, 2019: Tandem Diabetes Care announces Conference Call Following Data Presentations at the ADA Scientific Sessions
    • Jun 06, 2019: Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet bionic pancreas using dasiglucagon
    • Jun 04, 2019: Medtronic awarded $150M contract from Defense Logistics Agency
    • May 28, 2019: MiniMed 670G System Real-World Data on 8 Million patient days shows 71 percent time in range across all age groups
    • May 23, 2019: Beta Bionics starts clinical trial of iLet bionic pancreas
    • May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
    • May 15, 2019: Publication in "The Lancet Digital Health" of the positive results of the WP7 clinical trial with Diabeloop's integrated DBLG1 device in real life
    • May 09, 2019: New study demonstrates safety and effectiveness of the MiniMed 640G System reducing hypoglycemia compared with insulin pump therapy without CGM in type 1 diabetes
    • May 09, 2019: Xeris Pharmaceuticals announces first quarter 2019 financial results and highlights its pipeline
    • May 02, 2019: Insulet celebrates new global headquarters and U.S. manufacturing facility in Acton, MA
    • May 02, 2019: Insulet Reports First Quarter 2019 Revenue of $15S2
    • Apr 09, 2019: Diabeloop and ViCentra announce European distribution partnership
    • Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director
    • Mar 06, 2019: Xeris Pharmaceuticals announces fourth quarter and full year 2018 financial results and highlights pipeline progress
    • Feb 25, 2019: Medtronic wraps up scientific data presentations at the advanced technologies and treatments for Diabetes International Conference
    • Feb 25, 2019: Insulet announces fourth quarter 2018 revenue of $16S2
    • Feb 19, 2019: Medtronic receives FDA Breakthrough Designation for developing Personalized Closed Loop Insulin Pump System for diabetes management
    • Feb 19, 2019: Medtronic reports third quarter financial results
    • Feb 11, 2019: World first hybrid closed loop system now available
    • Feb 07, 2019: Bigfoot Biomedical and Owen Mumford announce commercial supply agreement
    • Jan 28, 2019: Defymed at ATTD2019 in Berlin-Germany
    • Jan 28, 2019: Insulet names Corinne Nevinny as board director
    • Jan 24, 2019: NIH funds first Artificial Pancreas study in the United States for pregnant women
    • Jan 17, 2019: New device achieves better blood sugar control in young children with type 1 diabetes
    • Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
    • Jan 07, 2019: Insulet names Wayde McMillan as Chief Financial Officer
    • Dec 17, 2018: Diabeloop at CES in Las Vegas to present its groundbreaking automated Insulin Delivery System for Type 1 Diabetes
    • Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine
    • Dec 03, 2018: Defymed – Winner of the first Innovation Prize
    • Nov 20, 2018: Medtronic reports financial results of second quarter of fiscal year 2019
    • Nov 19, 2018: Medtronic provides update on MiniMed 640G insulin pump
    • Nov 11, 2018: Kadimastem and Defymed awarded grant in the EU''s prestigious eurostars program for the clinical development of an integrated product for the treatment of diabetes
    • Nov 08, 2018: Medtronic delivers significant progress on global corporate citizenship efforts
    • Nov 07, 2018: Xeris Pharmaceuticals announces third quarter 2018 financial results and highlights pipeline progress
    • Nov 01, 2018: Insulet reports third quarter 2018 revenue of $15S2
    • Oct 19, 2018: Artificial pancreas could be a key medical breakthrough
    • Oct 18, 2018: Bigfoot Biomedical appoints Jyoti Palaniappan as chief commercial officer and Ian Hanson as chief technology officer
    • Oct 12, 2018: Health Canada Improves Access to New Treatment for Canadians with Type 1 Diabetes
    • Oct 09, 2018: Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant
    • Oct 04, 2018: Closed-loop insulin delivery system improves glycaemic control
    • Sep 10, 2018: Insulet announces Shacey Petrovic, President and COO, promoted to CEO, effective January 1, 2019; Patrick Sullivan will retire as Chairman and CEO at the end of 2018
    • Sep 06, 2018: Innovative solutions and exiting entrepreneurs: B. Braun Accelerator Demo Day
    • Aug 29, 2018: Defymed to present at EASD2018 in Berlin
    • Aug 24, 2018: Cadila Healthcare's Biologics manufacturing facility successfully completes USFDA inspection
    • Aug 21, 2018: Medtronic announces first quarter financial results
    • Aug 13, 2018: Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights
    • Aug 09, 2018: Medtronic launches patient engagement program that leverages gamification to help motivate and engage patients living with diabetes
    • Aug 02, 2018: Insulet Reports second quarter 2018 revenue of $12S2
    • Aug 01, 2018: Medtronic announces Paurvi Bhatt as president of Medtronic Foundation
    • Jul 16, 2018: Defymed wins MedFIT 2018 Start-up slams
    • Jul 12, 2018: Beta Bionics announces start of home-use clinical trials with the iLet Bionic Pancreas System and receives IDE approval from the FDA to expand its clinical trials to include the Senseonics Eversense CGM integrated into the iLet
    • Jul 10, 2018: First-Year Results from Medtronic and United Healthcare Value-Based Relationship Demonstrate Cost-Savings and Reduced Hospital Admissions
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook